0001104659-22-064100.txt : 20220524 0001104659-22-064100.hdr.sgml : 20220524 20220524073140 ACCESSION NUMBER: 0001104659-22-064100 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220512 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220524 DATE AS OF CHANGE: 20220524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vaccitech plc CENTRAL INDEX KEY: 0001828185 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40367 FILM NUMBER: 22954010 BUSINESS ADDRESS: STREET 1: THE SCHRODINGER BUILDING STREET 2: HEATLEY ROAD, THE OXFORD SCIENCE PARK CITY: OXFORD STATE: X0 ZIP: OX4 4GE BUSINESS PHONE: 44 (0) 1865 818808 MAIL ADDRESS: STREET 1: THE SCHRODINGER BUILDING STREET 2: HEATLEY ROAD, THE OXFORD SCIENCE PARK CITY: OXFORD STATE: X0 ZIP: OX4 4GE FORMER COMPANY: FORMER CONFORMED NAME: Vaccitech Ltd DATE OF NAME CHANGE: 20201014 8-K/A 1 tm2216229d1_8ka.htm FORM 8-K/A
0001828185 false GA 0001828185 2022-05-12 2022-05-12 0001828185 VACC:AmericanDepositarySharesMember 2022-05-12 2022-05-12 0001828185 us-gaap:CommonStockMember 2022-05-12 2022-05-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K/A

(Amendment No. 1) 

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 12, 2022

 

 

 

VACCITECH PLC

(Exact name of registrant as specified in its charter)

 

 

 

England and Wales 001-40367 Not Applicable

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

 

Vaccitech plc

The Schrödinger Building

Heatley Road

The Oxford Science Park

Oxford OX4 4GE

United Kingdom

(Address of principal executive offices, including zip code)

 

+44 (0) 1865 818 808

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trade Symbol(s) Name of each exchange on which
registered
American Depositary Shares VACC The Nasdaq Global Market
Ordinary shares, nominal value £0.000025 per share*    

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company  x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

*American Depositary Shares may be evidenced by American Depositary Receipts. Each American Depositary Share represents one (1) ordinary share. Not for trading, but only in connection with the listing of the American Depositary Shares on The Nasdaq Global Market. The American Depositary Shares represent the right to receive ordinary shares and are being registered under the Securities Act of 1933, as amended, pursuant to a separate Registration Statement on Form F-6. Accordingly, the American Depositary Shares are exempt from the operation of Section 12(a) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 12a-8.

 

 

 

 

 

 

EXPLANATORY NOTE

 

On May 13, 2022, Vaccitech plc (the “Company”) filed with the Securities and Exchange Commission (“SEC”) a Current Report on Form 8-K (“Original Form 8-K”) to disclose that it had dismissed BDO LLP (“BDO”) as its independent registered public accounting firm and appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm. The Company provided BDO with a copy of the disclosures it made in the Original Form 8-K and requested that BDO furnish a letter addressed to the SEC stating whether it agrees with the statements made therein. This Form 8-K/A amends the Original Form 8-K solely to include a copy of BDO’s letter, dated May 20, 2022, which is filed as Exhibit 16.1 to this Form 8-K/A.

 

Except as described above, all other information in the Original 8-K remains unchanged.

 

Item 9.01.Financial Statements and Exhibits.

 

(d) Exhibits

 

16.1 Letter from BDO LLP, dated May 20, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 

  Vaccitech plc
     
Date: May 24, 2022 By:

/s/ William Enright

    William Enright
   

Chief Executive Officer 

 

 

 

 EX-16.1 2 tm2216229d1_ex16-1.htm EXHIBIT 16.1

 

Exhibit 16.1

 

Tel: +44 (0)20 7486 5888

Fax: +44 (0)20 7487 3686

DX 9025 West End W1

www.bdo.co.uk

55 Baker Street

London W1U 7EU

 

May 20, 2022

 

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

United States of America

 

We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on May 10, 2022, filed by our former client, Vaccitech plc. We agree with the statements made in response to that Item insofar as they relate to our Firm.

 

Very truly yours,

 

/s/ BDO LLP

 

BDO LLP

 

BDO LLP, a UK limited liability partnership registered in England and Wales under number OC305127, is a member of BDO International Limited, a UK company limited by guarantee, and forms part of the international BDO network of independent member firms. A list of members’ names is open to inspection at our registered office, 55 Baker Street, London W1U 7EU. BDO LLP is authorised and regulated by the Financial Conduct Authority to conduct investment business.

 

 

 

 EX-101.SCH 3 vacc-20220512.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 vacc-20220512_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 vacc-20220512_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Axis] American Depositary Shares[Member] Common Stock [Member] Statement [Table] Document Information [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] American Depositary Shares EX-101.PRE 6 vacc-20220512_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 tm2216229d1_ex16-1img01.jpg GRAPHIC begin 644 tm2216229d1_ex16-1img01.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
May 12, 2022
Document Information [Line Items]  
Document Type 8-K/A
Amendment Flag false
Document Period End Date May 12, 2022
Entity File Number 001-40367
Entity Registrant Name VACCITECH PLC
Entity Central Index Key 0001828185
Entity Tax Identification Number 00-0000000
Entity Incorporation, State or Country Code X0
Entity Address, Address Line One Vaccitech plc
Entity Address, Address Line Two The Schrödinger Building
Entity Address, Address Line Three Heatley Road
Entity Address, City or Town The Oxford Science Park
Entity Address, State or Province GA
Entity Address, Country GB
Entity Address, Postal Zip Code OX4 4GE
City Area Code +44 (0)
Local Phone Number 1865 818 808
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
American Depositary Shares[Member]  
Document Information [Line Items]  
Title of 12(b) Security American Depositary Shares
Trading Symbol VACC
Security Exchange Name NASDAQ
Common Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security Ordinary shares, nominal value £0.000025 per share*
XML 9 tm2216229d1_8ka_htm.xml IDEA: XBRL DOCUMENT 0001828185 2022-05-12 2022-05-12 0001828185 VACC:AmericanDepositarySharesMember 2022-05-12 2022-05-12 0001828185 us-gaap:CommonStockMember 2022-05-12 2022-05-12 iso4217:USD shares iso4217:USD shares 0001828185 false GA 8-K/A 2022-05-12 VACCITECH PLC X0 001-40367 Vaccitech plc The Schrödinger Building Heatley Road The Oxford Science Park OX4 4GE GB +44 (0) 1865 818 808 false false false false American Depositary Shares VACC NASDAQ Ordinary shares, nominal value £0.000025 per share* true false 00-0000000 EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 3 26 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://vaccitech.co.uk/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2216229d1_8ka.htm tm2216229d1_ex16-1.htm vacc-20220512.xsd vacc-20220512_def.xml vacc-20220512_lab.xml vacc-20220512_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2216229d1_8ka.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "vacc-20220512_def.xml" ] }, "inline": { "local": [ "tm2216229d1_8ka.htm" ] }, "labelLink": { "local": [ "vacc-20220512_lab.xml" ] }, "presentationLink": { "local": [ "vacc-20220512_pre.xml" ] }, "schema": { "local": [ "vacc-20220512.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 65, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 26, "memberCustom": 1, "memberStandard": 1, "nsprefix": "VACC", "nsuri": "http://vaccitech.co.uk/20220512", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2216229d1_8ka.htm", "contextRef": "From2022-05-12to2022-05-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://vaccitech.co.uk/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2216229d1_8ka.htm", "contextRef": "From2022-05-12to2022-05-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "VACC_AmericanDepositarySharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American Depositary Shares", "label": "American Depositary Shares[Member]" } } }, "localname": "AmericanDepositarySharesMember", "nsuri": "http://vaccitech.co.uk/20220512", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://vaccitech.co.uk/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 17 0001104659-22-064100-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-064100-xbrl.zip M4$L#!!0 ( /,[N%18%;<*BA4 (EY 3 =&TR,C$V,C(Y9#%?.&MA M+FAT;>T];5/BRM+?K?(_S.74.>7>72#A751N(:+B&RS@ZEJWBAJ2 :(AB4E0 M\-<_W3,)! @J"J[[W/4<5V!FNGMZ^FUZ.L/N?X9]G3PPV]%,8R\BQZ0(889B MJIK1W8L,W$XT%_E/87-CM^="/^AK.'N1GNM:^7C\\?$Q]IB,F78W+F]O;\>' MV"U66@T<;E22 U1#BVWJS D=PUM"!JFN'75'%G/"R8+F.#;C2 E')L8C M%7-@N/8H?.9>(T?H#W!L=YXT^#"$JA_%4FG<]X$JBN8RI1=3S-C@#KLGI+2< MB'!M952%OP1_=EW-U5EA-R[^0FN?N90@F"B['V@/>Y&2:;C,<*--F%.$*.+= M7L1E0SV-U_1:/D4&.ZFB<-YNZ0"]IG>3)4ASNDZB!7,,;#36;Y.#5*2F9:.9)D_4MG;K,^>_7KU^AH5ZM MXLBRSA _O(*/_WM@*@-\6S'&!N$,[$3%97TG!CB=):C+[(,@'+3DEF<*!9GP MT3(P8(8]:C.GE6AQRR^ ./RS9> <("TU#U9RCJ2%P-NF.B*..]+97J0#^I$G MLF2YI*GUHR1ULT^-;^*#;T" K76X)JK:@S].U1S@_"A/#--@O%$;YE&E MF(VZRM]IJLH,KKGX%CI>P#K8FB*4VF8?)3DJI:-RPC4GKR/$@%D# M*J;E0V4U4I@(ZVY\"L5[L HIV8N J\FW33"JU.!"'*1G2L8C!=Z^0A(T=2\" M:YS0< EACMOSO"BJ*JRHTW!!_*MVS38?-(P0"D?%4#KB4PN"9($G8C:$1\P1 M/=#EY1T>RP!]A (UH]_8BS@::"$3=M5#-0UUC@VY<.O,>1_B,G^&(;__]88SS8/SI^'--Q9:.QFS"I\)" X52Y71:=F8' M3]#%0_%YV"S@KZG.4P'1FNT>P,(4)E/P(4W:YH:!2"T8Y+?,DC5%@/^AQ]+7 M\GGRJJ4,'-?LMXI<;J@!QM=T-*!W)&S,.>NWF?W+UF+"7M9%U0LT>$TJ$#.T M= V\K*"5J&#"#+$=\**J/-<8'%_2J>-4.PW75.Z*0\V)%-!+YY^?_6X\%%&0 MR'@XE?];HN1QNU4R^WW3X#S^?R\^?I>Y.?\1FOS T(3$0& R)P)]1IV!S0I> M!).'/CXPOVD:!4); %\HZT(4'A-XIS?CF(1=A%"(!X0X8D?/>[&83S\ MQ?]VK64CU1W2IW97,_($NTJ1PFX;]HOX:Q76!#$0K=<'.HO6:)=O>8(!LP 1 M=4T+4"8LUP<:;9LN.-T\2>)GCYKJ]I FZ>_(U/"V:0-SQ/!]G2IW!& 0Q]0U M=8=XC3XDT2Y/VG&B44=[@BT$?!HI_/.7G)%V!)N]?P-3B$_-874L\[$^LQ2Y M)>'N$+0T4:IK7?A( 2N)#@9P75Y4FN4#TF@6F^4&^1B* ME*]+Q\6+HS(I5<_/*XU&I7JQ4C%<2,<5=7J:T75-&'\0*\4(A.VI[>>9L/R" M^JNY.J5:7INXTA Z<,VE-.=S:<8+C%R9>!Y6Z^=DU[&HX6\O6]M2AN=MHE$_ M1X))LY8R3C%-DDU/]]N-\^%!TZGT -I[M_-!=)%"+GH:G]NU[L:1U-5:[H6\ MV1KOY\F%&2/REU?8JO>N]!^U^4SV9Z%H@$VOER^:I%ZN5>O-U5K1A4AK ]L9 M4)!&UX2!"J8LQ7SE)#%M(J>WU"\?1(K9(6Z/(14#6W,U %@>*CUJP&(6%9= ML[R=3'T +1^SX-P^+IT;!3[A_FAS ]A19Y9INV0+/T#V, K!+W-ZVRV(F%V^B:^L"NFZD*Q-YO-M+![*>*6UT8 MUU/I: 3S8$:8$9\B+%(XIR,(<+\1!+K J*\W%OEC6-=H6!.I51F667F7/'D7 MZ>TZZVH.GN*Z>/01+NZ/[ITYJ-V=9[\K*XA)PO"*E"!L)4K'I'96^K4Q2GE( MP> BP6A6[#&AA#K$L9B"Z2Z5:,!3U]G< !L-9L9>L9OX$_>O2<\X4)>V=09K MKNL@5PJO6I$B_+U%5=5_OS3B (O&N0+%U'5J.3!__Y5(9>VZMH_@@=FNIE#= MET7@I)_NVG75(!D^)R5,88K2(T4RD97 MIX9*\/>*ZIB0>\;N>"]=]9UKDUKIVA2GU@:/\('X-K/#%^)6N3GY7<_V\P+,?S7$^<.HHYT0( M^B^;=256CS5BI-RW='.$YUT?,_6*=\JG\#7'U,TT!R;*$N>NM;"F^&P'G:AI MY\EC3\,MT.N2W2MCP_-^T2L4\?Y@Y9,<;H2MU/G5X6WI-/&]O3(C'((<8FJ_ M#HY8NO)+8^I9SJ5?X%PBG'/:V:#\,^U*;:P%6AOG$I%"$S,Q2L_^YZ]$*K.# M$2'8V_V!IN/+3\7)[ N<3(9S\B33.>SO9VJ.F5@C)Y.1PC&CKLY&,&6J?BK& ME<(85X*75;MI/AKA;#O*?#\;E'JJHNNK9ML$M1"_ZA B7A6D4,/R+E*C]MVG MXE\NC'\S57(M=7@6SL@?>G%T>KMMG9W0".$UQGN1?/[ZX#J?/RK.1'48[D>U M8524U?&BS$#!7D$P:LP+D?B:.X IAI%;,QV7ZC>:M7CKN7& M>@H[S.,Z15)'Y4^UR*%<\_90"PS+H]5LGS2M'T=OUY#9K9ZWPT,VANWRILF* M%"X-<'HJ.053K9K]7WS>)6C#1))E@TIH%M4)&S)EX&H/F%^"H JA0I,^0.>R MN?&D6< IE7W4P<.OC*!\(XS&KV@SNE@/S]LWV?[%]LV)U%F!'@;Q10I?4RFR M)7U9)"DS-.][-)^9L!6L]4SCV1UWN_38OSVUOQ]U@>[WUV?/(HT4Y%PF37)R MCN2DW*^5]4E*]Y^_<@DYN^- 5YU92"TQ.+E3@DYA 3Y.TC_J'',ZK?!!.KQU M""830E21M+:Y!86W5%@?X'J'B+-$E3CHF#4T&6&RM3-#=<$@>@/=)<:S!PX^H@XL,=W.B,^WAMAMD'@Q-;?.Z4.'(H, M !!(FC'RVSJF#B3@.,S.:IBB7*%D1#\.I$Y9Y;TG-F5K;D@$YA5&QA>GL<)]VAG!S_[!V;B_.'B[9OP MUSSZ$TJ26/[FP3A))*08=T1Z'):)7EUO[HT0K5:*RIT0-DS]T )W.P1R#3=87;'[/ M+Z"Y7#;?D<9ZC0;-T_.)U&="',BFH&Z![L@I"E,.J,]48=18>5)23/3\\D=] M?BOU\3-)-9NAL<=T%Z]9Q1#%KG8ZB[96B<.GX\X9'9AZ=JUJM)BN3Z1.0&14 M"5#Y.K&^2L/$@#\Z]GOI6#ES_ 0)0K]HO,9NH48Z9+KM&N^)M(X,/_ M[)Y1Y#Q"S(E''&"(I0/YD&3R[]4660>'<;@J4[QZC[P(P_#^GTBAB>,X5?M1(77K$J7PCF&Q/3P$() M^&2W;?-+(R9J&#+)8,73RS,.%]HUS'X^3O3LRDA.M+D$AOHL_\%XZ+[H0?*6 M=P]#-/K\502MIYI35?L']UG-4,T I]&S]:W8\>K"/I)/BL7G[06LV-4%1T?[)EV9_1J/\,&3A MHP K72%JIJZMIJ9*RC)1Y?(K-%]*N=9GN9K->KKCIYUG!6;> S6DMQ MZ<(W(JY3T,D#U0>,8&B8W)%B$OPDTL3":U"PX[]7H;O++*H?H[[5)@3&KZ<> M<[KV39RB39PCEE=\3,>#+>'P+8P"I8 M_#D?TQ;P0,*BB1"(O@'9W @\MSD#&W=VD^$!Z+'/_ 11>9K;Q&.VP.-A>TMR M0IZJ,O*Q''$D)8$C/"^1/=O.C(96#6\%76%>PK4';+[,*)0NSN6$]&)&XO,N M:J43HDC^TF*]1JA6:K/GP)L;/= YIL..'G3.,/G^?N PW@W6@9\W$WY=K,9/ MDL651LA^CDP?(?9'#7"C_AI /;38[$%S8!QH,C44/"*@"J\&P\YX5Z]*;=41 M!\UJ(+G #[9G'NC>HN/L0C#=$ENU^ Z;XTF*)W;#95?M_KPT;J^DDZ?T6G-J MBZAZ;2[M\TKNOQ=OB:#KB+1!\% L# 4D \0WI/OF1ITI3+-<)T;*N'=>"!)K M90 P^%J'8#W3EHR>(!A9Q B6_J \NV(C\(VT!^ #'V$/@C6U! "*:0$%%AT06,QZ+9X0#%L4B\9XRS-CQZ0+G=6Z/:Z=-DX=BQ"G Z3-#?Y,'$RY MS9"X0.YNX0FVYT&_H=^E?:[KWZ8R?90XS*(V&A*_3(RS8AQ+X@2Q7(4<1C,Q M@*EPJKKZZ-N+K$%2V9#U02HZH"RJ[@LW]Y MOW]?VQXED'O4AO?&6+9IC^@"HZ;YRW\EO%PU]S< !.CZ":/ MMRGLCEW2HRJ!#Q$M>.[]@RHY.ZN-@<'["78';[+ 2)]9Z._XY3F!\[JV#@8I M$'=W-,#/8P3+,K&4%#A0 TO"'K&.IV="U%\RT0$['*4''B/ZI5"(L,;C^"3$ MQYF(;0(829F]H/8;P7N$8#%0FA.2+\WB" BP^!_7")G8K*8V!1-GSJJ 95BEBOR.XYB:VV<4MM\8!"PZ;KW9+PV^0:" M.1F *>)!6)]JA@,!K5<6O\8Y3PZ;@X?+LX?/[SML#GHG*<0[B4J'%\M7YDM7 MN!_'C.)C_7,, E:X5E2GS\:"M7.%_@AI9X]F%A48_(\5/[M+SQH%^)8P0B,*OS1 MQ0/J4L+OQ-C"0Q@5?3.Z/\_>5OAW1!'^53*J=X$=9K?76\7D18P:#S$\&[6> M4'@*Q6NV.HD_6YUU;'4^;L5#+J*N','6Y[+^$;N>]3RH&YFZ 55D].\'FNTY MZU>FRD2&+G XAT/", :9XV!#QM"$^ALE!@\DOT8,/>E3O8(X6 M ?$LH]2AWN8% M9JZ1>6V!@S?5-.8*GSO;]FOG%G0+/]=>D=O$FU3SPE.G9CSUZKSH_BC_)JBS MMSK-N KQH*L4RZ:G4ZEODOZX$R=7FJYKM$_*!C\B"+G=Z7T"^<)TWS+F><;/ M3>BUHOM+Y[2BR[SP(6&-=2O";&2.Z1J\?+[/#G# MY]L_3<3U^V1Z)YS&[X?!;S L\"_Q=/MZX97?EYC;;_$#?_[D=^![%MG)7I_=79['Q]?'HXNSRM=!/%Z3SLZ'%9,U*\IY.ZO*^S\&4H=T8]>8_OH0$J>CWXDRTK/;'1NG893AZ?AY8]&?W1U8YW;)UHU_F/_:;M2=I+' MJODSK73L&W;=[-\U+D>/KM/O2X- MCY;C!>-@XO>\9O7$V>9JVAMLW+1R*:/N@&25F,8I+%B>["EI8WZ/D/"9LQ#4[;<@OY@XL/0GTPN^Z/1^/S]NYI=*]^GE_WA^OT[01M:Y B\>9T)K456 MCBS87"?&EOT&/0ZNUA#W5&H6DG0='K30A>UX?2Z49M'21-T+1FNUE;E6:6U\ M]AZF5T.,<^:Z3MMUC^?.O_3!:3<9K MW)1&&J4?+?.S'M9Z 4U/X._#0_C3_LNUX>BPTX96I].I0@^[^/P/-J?DX1&; M(SAH=]J_A\WH'SBVW1;<4J7!YW.X=7X/D<5B8 MM\RVEX.U6C @=U3"5$M*]0X]_C[G)X+/!NXU*X[L]KDC]N<$K#0C+-4(5@NOL/84)X3&$HLHPIQ03?(1@V M53A=)1F<6[ZU0]NW1"6,QUJ@X,@:6ACYUN'Q#@&N.=-TCNR)1BT103]#N9"\ MWM5]9G^ZI9"0>PHS2CE$A>1,)>C8@ND$"(0B7QKO=$)!4I4+KNC^GA8PUC2# M0\MVS.RID%G%MM/X")&0I3R]IUSC/Z)!A)A7$LUB'6\*PED51!TBEN+<#)$* M:=0QE!"F#-7K<$/"$$,=)I"GH86M&$B,&5,21":(H\P:9"BLT.$Y!<8W5'%? MK@B4=!E7(B(2B#+\EBB5HJ:1,;BG3&:[3,%?LWPW5"Y!RR)=PA*]4/77ZT&M MUU1-&(PN $]QKY?F,X%^];PW%.M8M]Y1'1CN#)#1(1HI00[_2P&5!0N%JD/%[/&J:7@:S0C%.E?H5+6G[5K>> M_*/10-8TG9_ )8EI%TU^*2@/*2)WX2(WT5,G,"$8\D9C=4+T1N.;;YWK'#?7 M3XYV;3,V$Q+S;#,V2$EX!P[252)E\Z?GUM*7;4^\)F*NX;=(-PWKBMG+KKU- MK;;V>I1Q-J-),BK87!34/44%D MPL2H[=T._(M!I]OUT.M7__R-X&O]Z_OHBE&>--&E)'Y7#.5+=(-3VD1OJ: * M&ZE>HCO,<[LBKQBG"G5DFG%J*!B*G9KH+(@:,?+] W3OJ$BDNNUWY[IC8S+= M#,/I=!H(.<%3J>YU0&1ZF.# 8)/KN5IM5BN_P^C73),Y^0F^.)L^G_79IQ$5 M+_(>;GPA'S%^@^/WR8\O_2?X\_W,I&\:\<<43QY>\/[M\-L-N_ELN*K_'W?? M%5NV-!G3%"/X&4*W/1M?&=ZT$4@U"NNU6A1^NNX-',XK@,T99^)^$SPZ/S\/ MG;6"KB%GL>*5=".TYAAK.E<&*]N!9T(;+,@C?&+FA&7P65@8'T'91NBS LHJ M:$)7<)J28"0G(1@ 7X^^/ZV@N?9'&&=S^!#KV,F6!@?W:Y'?B"J*5F8=#HN; MH;YYR*C>2"A,&VB)42NT1R<)YM":+;-FF?4Y\^ZBTYF3)I@09B@90XH'^;V% MUVMG41VN*J9*JO22#G'.(:+O.>9LR&CB(8/5B!J;M3K#A.X7K+(?"R'A MDL!-+5?L6I8QN 6P\%?+IDM324X_@/O(#N!Z;I6W]K CHU.+KJNO7I$+EKVK1YT/8TLX72*]?&B@[;GCU-O_I# M7R&T %*D@ECI'=?4G?SJ:90;5Q)8D365M3("(C*CRC#(\Z5:4;C.C*7_M[0- MLOMH#X6_(V2.XV-#!@KE?S#6GM7_K4%")AT;Y./D^T.17LXW60ZW+ GAHB:4 M\]6ZT8+ I3)(K-6@76]*\1KV)'%2.RAVYE<\WR[Y41T*<##3R<+38YQ8',-Q M3E2\$YS8^K)M\D!O)]BA7PP/W7KG*[ES^XW,D'*CJQ5_H76*.^MOZB_XX\1. M<&C_<[W-J7U,-] M/A2.M5&80+MF5 [%1C .;Y8MN,7<]=]-J,U,)A_<$Y+DRD4&75TQKWK+9B)3 MS$37T-0BX21R$&&ULU9U=4^,X M%H;OMVK_@R=S'4)"L[O--#N5#C"5FNZ&(4S/[MY0BJTD*F0I(\F0_/N5_!'\ MH>,X+(A57]#!.<=Z=1Y9TK$E\^GG34R#1RPDX>R\-SPZ[@68A3PB;'G>^WW6 M'\\FTVDOD JQ"%'.\'F/\=[/__SK7P+][],/_7YP13"-SH(+'O:G;,%_"KZA M&)\%OV"&!5)<_!1\1S0Q1_@5H5@$$QZO*598?Y$5?!:<'@U/YD&_W^&\WS&+ MN/C]=KH[[TJIM3P;#)Z>GHX8?T1/7#S(HY#'W4XX4T@EVX\UQ_B]S_T0) M>S@S/^9(XD#'B\FSC23G/5-N7NS3R1$7R\'H^'@X^-?7+[-PA6/4)\S$+<2] MPLN8W_/CQXR#]MC!M6&[F@A9EG P*.;LSZV\CM7,H&Y\.LB_+IJ3EU"71 MDIS)M"9?>(A4VD+V*@I "_-;OS#KFT/]X:A_,CS:R*A7<$J#+3C%MW@1F/\U MZ%VICR@,B<+A2L,]2AX&YOO!A.OFJ\6FGBN!%^<]8Z<+&(V.3XIH:G:>$K?0H1)G/('"BZZ>U <5I2/\;QW. ^2&[5]>VU M(DH/4Y@ZO+TNQM7X4&F%C],VB1K%C;)PKVK6APDCIJ_[HG^MZ,8;I8<> M'!7*S0D/Z)H44<8^'UN&0=\,1(F6H_3'S#)74FBA/*P(H*87YJ(9.5E46>+P M:,D?!Q$F.GRCX9\?S,=^]C&+'R;W1;EF$!0QRBN+IPK'LC@Y17-,TR+OM4N[ MQ^!_UKU Q*-3GC:;CE9FUU+.0,Z5;RB5-2].M'2_-AT+90O"X8UCS$/+6 M>I3CK.7T BXB+/1,[OA9$>421^<])1)+Q=\%UH0B*:\7,\7#A_&&V%I=O;Y- MEU=%:!UBZ\C:&0"@H+I:F+TOG;+0BWS(AK#8;%^51W/VL \&&&>^5SD$9'3L M,Y'[H47^:T$I1L]#>[U7HY;6#@)W\E)PSP0.1;VC\_2#O8B[UW-\;CF+.T?B">(A9UTWO; M%?]_ :55,=A_O0J*PR:5=_JL[9-(8W'_P7&@#YQMV>1"47Z50:);D/5ER2(C MZHJBI3W*%1,/PMS4^Z;3HP/C?(%E*,A:E::#0+A+ECY%O2X;[$K<]R2W>$FD M$FE==O.%]J[%ZN(!COWZP9F.>RYCQA)$;_7,0.S!4;;TB$)#-A3\#^Z#_UN" MA,*";KO$OV;L$0*;9"I3!<,=6N/.%BE0R#^YA[$;(4I-<\3 M$>MT133M/8(!B(=P_/U]<5P^FNF%'L.Z$]FY> JEJA_B\@_W7&YT-L\C/:,0 M'8C4C#UB85,.4?CX7A0N6=2506[J'8&R[K8'%*X!7!$9(IIIO-+']CSM:IA[ M!,*N_6WOV;T$QK\Q$IU1[(R] U%5#F)PF&5/$B$J\EK[)1!YJV0PX@Z3Z4Q8<;.%*;,.L"WJ54MO(F^1#4;? M81*=B9OHV@A$IRS"FU_QMBW\-5-OXF_3#0)PF#QGZFX$BT:W$C^"/)]CKM8U'S\ V(33Y(Q7DJ7K2:;)+1Y M,- .TV\S/HT%1G!3+UOX$.:Z7##*#G/I+]P\@UIQUGIGNV[E0;2MDL&(NTR) MS1Y%"78>NZ\]B'%5*Q3<%^_T>$%P_Q!$:4UF#7["\KM7P'-+JZD'08=U@P < MIK4S3DFH8\667_5L5A!$[=%OVGD0>D T&'>'&>R-P*9%8)TXI(L"S39H<;U8 M0#TZ;.\!ASWB01X.4]F:Q*F4"1:'4FEX^EV^%H?F?V M_0/]5,W* P)6R6#$'::RW_B=0.:U1;-M/.<4WB!E,?0@[I!J,/0.L]:*,GO0 M*R8>A+NI%PRTPZRUN/@N-^$*L26&UZW8+#T(.R@;C+[#;/:YZUMVZM.7_O7I MRPY]NL-LMA"6;7;0U^/UG)(E@G=CMCAXQ %2#R&QU>RMD&1[XTH5NM(?[#"L MIAY@@'6# %QN34XBHG"4B;PB#+%0IXJ[S:+ _8A]7CY@Z5(%D)#SY[U_8$I_ M9?R)S3"2G.$H2U;:GJL +AZPV:\?!./\"?!W3A-FWFB2OHP4N%ZLIMZ L.D& M 3A_V)LOR-^-LB*H;>,&BJ!D/O?&WV+$:4?DZDKH1L[9TJAMZ$ MOJD:#+WSU=>7,19+W5'^(OB36N6;J]L06!V\00&K!Y$X7V5]N7E^%42VJ[25 M1\/:'QAVZ1")TW?8QCP.0[.H)IM)L @)@ 5L[P&-/>)!'@Y3\6NUPJ(\JTOE MF0JU+7?9Y^4!FTY5 DY3\7+K^AH'>:=\D?$7L0R5J%VQO!0XS-8RRYNU8[I'6=3N -J.ZU 1&ZWQK] M_)+7[*V[UXE*_P"/5MQZFZ3%SQM@>RL!O]I4*NF+OY!?Y&UL MS9WO;]NX&;$ =Q\YN0'/-'5(W.027)EGM]K850T%+C"-$)C-* M3IS_?OPAR1+%1U)R=R3[HG6E[T-]*7Y,4K+XZ-U/NTV*'@G/$D9/1M.#PQ$B M-&)Q0MEB?G$Q0EF.:8Q31LG)B++13S_^^4](_'GWE_$8G2Y?E#=CR9/#T]'5#VB)\8O\\.(K895N BQ_DV MJTH[W!T6?W3XNS2A]\?RKQ7."!+GBV;'NRPY&+F([L@&CQ,JSUM$1F64+,46-WW[]NU$[2VE+>5NQ=/R&$>3TDY5LMB;=.AK M3K+D.%/V+EF$<]7LO8=!H$+^;US*QG+3>#H;'TT/=ED\*D^^.H.03N46J MFL?Y\X- *4LD":-BVQTGMW8S*><3&3^A9(US$LL#O94'FOY#'NB[8O,E7I%T MA*12\ '6ZVVCK")HXMKL#>$)B\_HZUR;T9[LB^\.SW]#!>KQSJNP9#E.7V6^ M'NG<]A5YW1G?Q[D_TZ*?)Z\[T[7(/\1VWK;\XM-K/Z^IW'@I/C4LDETN!C 2 MER9E$1T]L#J"&AB*LJO26=0H-Y6].>/MNLN1495YB[.5*GB;C=<8/X@#S*83 MDN99N64LMXP/IT7__5VQ^9L<(XBR[OEWD++H_W259>315U9/1 /W$ MK(:,/.5E73"/>DY(H9A$3 QG#_DXU:=>A]]RMAEDHSAS;(#X6[JJRM>G6E@ M*M*0<9*Q+8_(BUJZ7INA9[5PN$E%A)RV$3K^O!C]J&2(W2(E1%^E]+_O)ONB M7T/4(XXBB8%VB,D#N'9;A'DU1NG*/B8L4JH>^F7NT!CJ&D)29_6.RX##9K@E"&H%H.^RBBDPGR"M!2E=M12 M[W8-2MV4"8;<%Q0(-4-@PTN-AT866V:;6("GRV=0?2!;QY$'V,5UU::A;3T:4!>M?#0*=MABPH M0NS>0$@JN7].EAS3+)&=62\H;:GSRQ# ;.N2Q- %Q0I@#KY4J?3^:5G::H]W='#44OIFB# JLF.(0N*&KLWD!D'F)95.RZ5+$!83&]]J$B]-U#F6\X; MSN'1!Y:Z0J7/;,D*I L"EAYSK4=*M+P!B\?1Z(SF2?XLERY<;2V/&]DEKOB MS)5J)3S>J)B+7HKC](+&9/<+>0;KUM*YY0*PV03#$ 5$AMT9@$8A1DJ-A-P; M'#<\V<@G;Y.H9]AH"]WB 1EM\F&J @($L 804JC1XF+N>U19XMU%+(!-;A.] M%*^'%%#O%I@>VTUN '% ^'0[!"@20:@9Y1NF"QHQ_L!JCTO,V59TAL]S%L,S MEIXHMV -JD(3K\Z0@" ;XA- K1'Z1C_3@IA<1JT*0+($;]2=QK$X65GQSV5" MR10\!U:M6\(Z[#:YL@@#H@EV!S!4*-^4'Y",0=^ ;5'K! MIFW5"LU>%AXR+6]]P,@ .;^1(;Y149.M:W[#V6-"(W@:#IFG2WM5H37B@-(WU=C):[1N+&Y;E./U/ M\M!YD6X7>T'$:M@*2D,9'BXV>WW0Z!@D@GQ==!?8RA] K,O5C/W.?J6VV:I^ MFJ[O# ($FZ-V7@-]=T6+?#2U9)43#/0,S=W.&MIBJFKGVKXPFKEMJ-7*ZOLM M-+Z^T#()7WISQRC\<$%;XJJU(7-EBYO[@VAUP)39\DJ&E,[CG7N9#"RS=^6U M?M-.-;"7.X)H8=--:]@N]WMHT5]YDHNCRZPX6UK\,F1[!A'0N6KI3IME MJUM%01#0Y,((- _ U-*'B!1DLAB;KP6)MF*\ M?)[.5LLD;^7,LTNSOZ[^ALHH#PAY'@9L)LVAH*X) H,.8ZV+ ME4**2JVOQ0[[(6S=/RE8>YL4K'LF!>L0)P7KH9."M==)07EHG:9$]%'7JS19 M8R!I8J?:-1@=EDU&+-*@<(']@7U'%8+V,3ZR;:JT:[5TON?B@Z6F@,Y9OLTN MFU7"39LH"$ZZG+52;NI$>/4,RU+M@XUMG.0DUH;.$XIIE."T2MUHNWO>'^*, MF('F*WAZ]&%P-,QD"RD=5N98K +W:3A]W';7#W'\2M+T%\J>Z(+@C%$2Z_LM MME^7NO5NG[KIL=U\\ 80!X'4$(? XSDFPDI#<\1+Q3M/& M2G&K-B!N.@U"Z\:+G"/[^;*.\KB<,R<<1WGR2#[@'!?^P#I#O:5ELYZ^I) $A8O/5 MD<6&HU+KC8?%!J?I^VV64)+!@Y*AE!256F\\G&T( M7XOA[F?.GO*[(H,B+?#PBNI.@/<4714/,E2WWZ((@::-+D2H4U+[Q5H'K7H^^L2O6$_/"T MKR%R/%NV�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end